Trilogy Capital’s Strategas Macro Thematic Opportunities ETF SAMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.9M Buy
709,244
+34,001
+5% +$1.5M 1.31% 18
2026
Q1
$26.5M Buy
675,243
+206,161
+44% +$8.23M 1.17% 22
2025
Q4
$18.1M Buy
469,082
+16,715
+4% +$635K 0.81% 31
2025
Q3
$16.9M Buy
452,367
+15,725
+4% +$557K 0.78% 28
2025
Q2
$15M Buy
436,642
+132,593
+44% +$4.11M 0.73% 30
2025
Q1
$8.88M Buy
+304,049
New +$9.24M 0.47% 35

Other funds holding SAMT

Trilogy Capital's SAMT Position: Q2 2026 in Review

Trilogy Capital increased its Strategas Macro Thematic Opportunities ETF (SAMT) stake by 5% in Q2 2026, buying an estimated $1.5M and bringing the position to 709,244 shares worth $33.9M. The position accounts for 1.31% of the portfolio, ranked #18.

Trilogy Capital first reported a position in SAMT in Q1 2025 and has held it in 6 quarters since. 19 funds tracked by Wall St. Rank hold SAMT as of Q2 2026.

  • Trilogy Capital held 709,244 shares of Strategas Macro Thematic Opportunities ETF worth $33.9M as of Q2 2026.
  • Trilogy Capital bought 34,001 Strategas Macro Thematic Opportunities ETF shares in Q2 2026, an estimated $1.5M.
  • Strategas Macro Thematic Opportunities ETF made up 1.31% of Trilogy Capital's portfolio in Q2 2026, its #18 holding.
  • Trilogy Capital first reported a position in Strategas Macro Thematic Opportunities ETF in Q1 2025 and has held it in 6 quarters since.
  • 19 funds tracked by Wall St. Rank held Strategas Macro Thematic Opportunities ETF as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.